GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Henry Schein Inc (NAS:HSIC) » Definitions » Beneish M-Score

Henry Schein (Henry Schein) Beneish M-Score

: -2.24 (As of Today)
View and export this data going back to 1995. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.24 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Henry Schein's Beneish M-Score or its related term are showing as below:

HSIC' s Beneish M-Score Range Over the Past 10 Years
Min: -2.71   Med: -2.49   Max: -2.24
Current: -2.24

During the past 13 years, the highest Beneish M-Score of Henry Schein was -2.24. The lowest was -2.71. And the median was -2.49.


Henry Schein Beneish M-Score Historical Data

The historical data trend for Henry Schein's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henry Schein Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.29 -2.39 -2.48 -2.49 -2.24

Henry Schein Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.49 -2.46 -2.46 -2.52 -2.24

Competitive Comparison

For the Medical Distribution subindustry, Henry Schein's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henry Schein Beneish M-Score Distribution

For the Medical Distribution industry and Healthcare sector, Henry Schein's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Henry Schein's Beneish M-Score falls into.



Henry Schein Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Henry Schein for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3242+0.528 * 0.9681+0.404 * 1.0839+0.892 * 0.9756+0.115 * 1.0416
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0934+4.679 * -9.5E-5-0.327 * 1.134
=-2.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $1,863 Mil.
Revenue was 3017 + 3162 + 3100 + 3060 = $12,339 Mil.
Gross Profit was 925 + 995 + 975 + 966 = $3,861 Mil.
Total Current Assets was $4,488 Mil.
Total Assets was $10,573 Mil.
Property, Plant and Equipment(Net PPE) was $823 Mil.
Depreciation, Depletion and Amortization(DDA) was $248 Mil.
Selling, General, & Admin. Expense(SGA) was $2,956 Mil.
Total Current Liabilities was $2,683 Mil.
Long-Term Debt & Capital Lease Obligation was $2,247 Mil.
Net Income was 18 + 137 + 140 + 121 = $416 Mil.
Non Operating Income was -22 + -13 + -17 + -31 = $-83 Mil.
Cash Flow from Operations was -32 + 231 + 274 + 27 = $500 Mil.
Total Receivables was $1,442 Mil.
Revenue was 3371 + 3067 + 3030 + 3179 = $12,647 Mil.
Gross Profit was 999 + 914 + 945 + 973 = $3,831 Mil.
Total Current Assets was $3,988 Mil.
Total Assets was $8,607 Mil.
Property, Plant and Equipment(Net PPE) was $667 Mil.
Depreciation, Depletion and Amortization(DDA) was $212 Mil.
Selling, General, & Admin. Expense(SGA) was $2,771 Mil.
Total Current Liabilities was $2,224 Mil.
Long-Term Debt & Capital Lease Obligation was $1,315 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1863 / 12339) / (1442 / 12647)
=0.150985 / 0.114019
=1.3242

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3831 / 12647) / (3861 / 12339)
=0.302918 / 0.31291
=0.9681

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4488 + 823) / 10573) / (1 - (3988 + 667) / 8607)
=0.497683 / 0.459161
=1.0839

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=12339 / 12647
=0.9756

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(212 / (212 + 667)) / (248 / (248 + 823))
=0.241183 / 0.231559
=1.0416

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2956 / 12339) / (2771 / 12647)
=0.239566 / 0.219103
=1.0934

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2247 + 2683) / 10573) / ((1315 + 2224) / 8607)
=0.466282 / 0.411177
=1.134

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(416 - -83 - 500) / 10573
=-9.5E-5

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Henry Schein has a M-score of -2.24 suggests that the company is unlikely to be a manipulator.


Henry Schein Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Henry Schein's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Henry Schein (Henry Schein) Business Description

Traded in Other Exchanges
Address
135 Duryea Road, Melville, NY, USA, 11747
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Executives
Stanley M Bergman director, officer: President and CEO C/O HENRY SCHEIN INC, 135 DURYEA ROAD, MELVILLE NY 11747
Bradford C Connett officer: CEO, NA Distribution Group C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Brous David B Jr officer: CEO, Strategic Business Group C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Walter Siegel officer: Senior VP & General Counsel C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
James P Breslawski director, officer: Executive Vice President C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Michael S Ettinger officer: SVP, General Counsel, Sec. C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Mark E Mlotek director, officer: SVP, Corp Bus Dev Group C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747
Lorelei Mcglynn officer: SVP, Global HR & Fin. Oper. C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Gerald A Benjamin director, officer: Executive V.P and CAO C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747
Ronald N. South officer: SVP & Chief Financial Officer C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Philip A Laskawy director 9 CREAMER HILL ROAD, GREENWICH CT 06831
Kurt P Kuehn director C/O HENRY SCHEIN, INC, 135 DURYEA ROAD, MELVILLE NY 11747
Scott Philip Serota director C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
Reed Vaughn Tuckson director C/O UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST, MINNETONKA MN 55123
Steven Paladino director, officer: Executive V.P. and CFO C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747

Henry Schein (Henry Schein) Headlines